Drug intelligence / Profile preview

eIF4E siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral, Intraperitoneal, Subcutaneous, Intramuscular, Intradermal, Oral, Intrathecal, Parenteral, Implant
01

Overview

eIF4E siRNA is a small interfering RNA (siRNA) designed to target and silence the expression of eukaryotic translation initiation factor 4E (eIF4E). eIF4E is a key component of the eIF4F translation initiation complex, which binds to the 5'-cap of mRNAs to facilitate ribosome recruitment and cap-dependent translation. Overexpression of eIF4E is common in many human cancers and is associated with the selective translation of oncogenic proteins involved in cell survival, proliferation, and angiogenesis. By knocking down eIF4E expression, eIF4E siRNA inhibits tumor cell growth, induces G1 cell cycle arrest, promotes apoptosis, and enhances sensitivity to chemotherapy and radiation therapy. It is primarily utilized as a research reagent to study translational control and target validation in oncology.

Other names
eIF-4E siRNAeIF4E siRNAeIF 4E siRNAeukaryotic translation initiation factor 4E siRNA
02

Targets

EIF4E (Eukaryotic translation initiation factor 4E)

Beyond the preview

Go deeper on eIF4E siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eIF4E siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call